Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

While artificial intelligence (AI) has been one of the hottest investing trends, GLP-1 weight loss drugs are a close second.

The national shortage was caused by damage to a manufacturing plant in North Cove, North Carolina, that flooded due to Hurricane Helene, which hit the area in late September. The Baxter plant in North ...

Investigating America’s Drug Shortage Crisis,” a series exploring the causes and possible solutions of a problem plaguing ...

BMO Capital Markets analyst Evan Seigerman called it “another positive indication” for Eli Lilly, whose top-selling diabetes ...

compounded drugs sold by 503B pharmacies “may not be identical or nearly identical to an FDA-approved drug unless the ...

On October 2, 2024, the U.S. Food and Drug Administration (FDA) determined the shortage of the tirzepatide injection, a glucagon-like peptide ...

The FDA confirmed Thursday that Eli Lilly has increased production of its blockbuster weight-loss drug Zepbound and type 2 ...

In my pharmacy practice we recently fell short and were unable to fill a prescription for isoniazid due to a national shortage of the drug. It gave me pause to think that even old reliable drugs ...

But last week, when the FDA removed Lilly’s tirzepatide from its drug shortage list, it erased the compounders’ qualification to manufacture one of their two new cash cows. In response ...

The FDA says the shortage of tirzepatide injection — a glucagon-like peptide 1 medication used for diabetes and weight loss — ...